Biocryst Pharmaceuticals Ratios (2010-2015) | BCRX

Ratios Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015
Profitability
Gross Margin 90.62%99.84%97.89%99.66%99.21%99.12%97.97%87.75%
EBT Margin -90.53%-61.11%-215.00%-264.30%-231.97%525.00%972.33%-181.85%-1,618.27%-338.97%-71.50%-249.02%-874.83%-395.71%-301.63%-228.95%19.07%-129.87%
EBIT Margin -91.58%-61.75%-211.57%-243.95%-211.37%431.12%877.24%-149.58%-1,478.93%-289.87%-59.94%-213.59%-792.56%-358.55%-278.30%-211.40%24.53%-119.80%
EBITDA Margin -91.58%-61.75%-240.11%-243.95%-211.37%520.95%1,059.05%-127.12%-1,483.68%-335.08%-51.36%-293.20%-999.18%-269.67%-216.75%-220.10%22.04%-132.25%
Operating Margin -91.58%-61.75%-211.57%-243.95%-211.37%431.12%877.24%-149.58%-1,478.93%-289.87%-59.94%-213.59%-792.56%-358.55%-278.30%-211.40%24.53%-119.80%
Net Margin -90.53%-61.11%-215.00%-264.30%-231.97%525.00%972.33%-181.85%-1,618.27%-338.97%-71.50%-249.02%-874.83%-395.71%-301.63%-228.95%19.07%-129.87%
FCF Margin -77.44%-34.94%-64.29%-199.47%-76.28%1,061.81%550.17%-315.08%-352.62%-331.60%-42.77%-259.28%-484.45%-266.65%-256.24%-62.86%81.41%-116.52%
Efficiency
Inventory Average 0.90M0.58M0.26M
Assets Average 100.46M87.36M81.15M78.16M70.17M60.77M52.17M43.41M46.56M51.04M46.13M92.68M139.55M137.00M133.37M140.02M144.57M
Equity Average 32.65M20.42M18.98M19.40M12.72M4.67M-1.65M-5.94M-2.82M1.14M-3.42M42.18M86.77M79.54M70.00M70.23M70.07M
Invested Capital 65.50M39.27M26.04M14.81M23.15M15.66M9.78M-0.45M-2.84M-9.05M3.41M-1.13M-5.72M90.09M83.45M75.64M64.37M76.09M64.05M
Asset Utilization Ratio 0.390.370.180.100.120.050.120.340.370.190.130.100.130.270.31
Leverage & Solvency
Interest Coverage Ratio -39.79-11.04-9.52-4.31-8.77-4.51-10.42-5.81-5.10-5.95-9.48-9.54-11.53-10.974.09-10.61
Debt to Equity 0.761.152.031.301.923.07-66.08-10.56-3.328.80-26.64-5.240.400.470.390.47
Debt Ratio 0.280.320.360.370.390.470.520.640.750.560.610.690.220.230.200.22
Equity Ratio 0.600.360.280.180.290.210.15-0.01-0.06-0.230.06-0.02-0.130.630.610.550.500.510.46
Times Interest Earned -39.79-11.04-9.52-4.31-8.77-4.51-10.42-5.81-5.10-5.95-9.48-9.54-11.53-10.974.09-10.61
Valuation
Enterprise Value 210.71M178.31M-31.34M114.68M80.61M69.96M179.08M195.21M190.13M36.65M45.80M62.61M352.25M411.04M596.90M633.72M574.64M801.09M585.52M988.37M764.60M
Market Capitalization 221.88M232.25M172.27M124.61M111.68M222.36M195.21M214.09M72.25M60.60M82.38M394.84M449.09M628.29M765.82M701.78M873.86M653.05M1,082.73M834.93M
Return Ratios
Return on Sales -1.18%-1.47%-2.97%-5.32%-5.57%-18.06%-6.98%-2.04%-2.18%-2.07%-2.23%-3.72%-3.40%-1.09%-0.94%
Return on Capital Employed -0.56%-0.75%-0.62%-0.66%-0.77%-1.04%-1.04%-0.86%-1.01%-0.68%-0.41%-0.57%-0.74%-0.47%-0.47%
Return on Assets -0.46%-0.55%-0.54%-0.55%-0.69%-0.86%-0.84%-0.69%-0.81%-0.40%-0.30%-0.37%-0.43%-0.29%-0.29%
Return on Equity -1.43%-2.34%-2.31%-2.23%21.83%6.25%13.88%-31.00%10.97%-0.88%-0.48%-0.64%-0.82%-0.58%-0.60%